CELEBRATION, Fla., Sept. 20, 2024 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has…Original Article
FDA Approves Miplyffa (arimoclomol) for the Treatment of Niemann-Pick Disease Type C
